Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease
Takuya Watanabe
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6118-6118
Open Access | Times Cited: 21

Showing 21 citing articles:

Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis
Weixuan Wang, Mingjie Liang, Lexun Wang, et al.
Biochemical Pharmacology (2022) Vol. 207, pp. 115357-115357
Closed Access | Times Cited: 23
Catestatin in Cardiovascular Diseases
Joanna Kulpa, Jarosław Paduch, Marcin Szczepanik, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2417-2417
Open Access
Vasostatins: new molecular targets for atherosclerosis, post-ischemic angiogenesis and arteriogenesis
Rosalinda Madonna, Serena Barachini, Sandra Ghelardoni, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 2, pp. 132-139
Closed Access | Times Cited: 3
Chromogranin B Protects Human Umbilical Endothelial Cells against Oxidative Stress
Elena Grossini, Sakthipriyan Venkatesan, Mohammad Mostafa Ola Pour, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10296-10296
Open Access | Times Cited: 2
Diagnostic value of peripheral blood miR‐296 combined with vascular endothelial growth factor B on the degree of coronary artery stenosis in patients with coronary heart disease
Lei Xu, Ting Fu, Yu Wang, et al.
Journal of Clinical Ultrasound (2023) Vol. 51, Iss. 3, pp. 520-529
Closed Access | Times Cited: 6
Chromogranin A: An Endocrine Factor of Pregnancy
Michalina Bralewska, Tadeusz Pietrucha, Agata Sakowicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4986-4986
Open Access | Times Cited: 5
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis
Dhanya R. Iyer, Janani Venkatraman, Émeline Tanguy, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Open Access | Times Cited: 5
Quercetin protects human coronary artery endothelial cells against hypoxia/reoxygenation-induced mitochondrial apoptosis via the Nrf2/HO-1 axis
Jiejin SONG, Shuang Li, Boyong ZHANG, et al.
Biomedical Research (2024) Vol. 45, Iss. 5, pp. 197-207
Open Access | Times Cited: 1
Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration
Agnieszka Ochocińska, Marta Wysocka‐Mincewicz, J Swiderska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2151-2151
Open Access | Times Cited: 3
Vasostatin-2, angiogenesis and collateral function
Ingrid Fleming
European Heart Journal (2023) Vol. 44, Iss. 19, pp. 1745-1747
Closed Access | Times Cited: 2
Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction
Weixian Xu, Yuanyuan Fan, Yao Song, et al.
World Journal of Emergency Medicine (2022) Vol. 13, Iss. 3, pp. 169-169
Open Access | Times Cited: 3
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Laboratory biomarkers for the prognosis of chronic heart failure
A. P. Roytman, Т. Е. Кузнецова, Igor Belyaev, et al.
Laboratory Service (2024) Vol. 13, Iss. 3, pp. 5-5
Closed Access
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
Wenjun Liu, Yuqiang Ji, Weiwei Zhang, et al.
Computational Intelligence and Neuroscience (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 2
The potential of catestatin in the diagnostics of cardiovascular diseases: current data and perspectives
Olena Pankova
Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini (2022) Vol. 2022, Iss. 2, pp. 43-48
Open Access | Times Cited: 2
КАТЕСТАТИН - НОВИЙ РЕГУЛЯТОР СЕРЦЕВО-СОСУДИННОЇ СИСТЕМИ
Дар’я Чорна, Катерина Боровик
(2023)
Open Access
Assessment of Biomarker Profile in Patients Post Carotid Angioplasty and Stenting
M. М. Tanashyan, Vladislav A. Annushkin, Anton A. Raskurazhev, et al.
Annals of Clinical and Experimental Neurology (2023) Vol. 17, Iss. 2, pp. 5-15
Open Access
Evaluating the diagnostic efficacy of secretoneurin in ıdentifying heart failure among dyspneic patients in the emergency department
Tahir Talat Yurttaş, Ali Cankut Tatlıparmak, Sarper Yılmaz, et al.
The Annals of Clinical and Analytical Medicine (2023) Vol. 14, Iss. 11
Open Access
The association of plasma pancreastatin levels with insulin resistance in patients with gestational diabetes mellitus
Gökçen Ünal Kocabaş, İlgın Yıldırım Şimşir, Banu Şarer Yürekli, et al.
Obstetric Medicine (2023) Vol. 17, Iss. 4, pp. 221-225
Closed Access
Catestanin – a promising biological marker for heart failure: A review
Amina M. Alieva, Natalia V. Teplova, Е. В. Резник, et al.
Consilium Medicum (2022) Vol. 24, Iss. 10, pp. 726-731
Open Access
Vasostatin-1 as a potential novel circulating biomarker in patients with chronic systolic heart failure: A pilot study
Giuseppe Pinto, Barbara Colombo, Adriano Autieri, et al.
Clinica Chimica Acta (2021) Vol. 526, pp. 49-54
Closed Access
Page 1

Scroll to top